美国FDA近日宣布，口服药Addyi（氟班色林）再度拓展适应症，正式获批用于干预65岁以下绝-经后女性的性-欲减退障碍（HSDD）。业内专家表示，此次获批打破了该药物对绝-经女性的使用限制，适用人群将进一步扩大。

12月15日，美国食品药品监督管理局（FDA）批准口服药Addyi的适应证扩展，用于治疗65岁以下绝经后女性的性欲低下症（HSDD）。 Addyi有着“女性伟哥”之称，是全球首个用于治疗“性欲低下”的药物。它曾被寄予厚望，被认为有望成为西地那非后的又一款重磅药物 ...

The Food and Drug Administration has admonished Sprout Pharmaceuticals for running a radio ad that omitted all possible risks associated with its controversial female libido pill and also for giving ...

Add Yahoo as a preferred source to see more of our stories on Google. Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. When Kara became disinterested in sex with her husband, she knew their relationship wasn't the problem ...

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

Sprout Pharmaceuticals Inc. is relaunching Addyi (flibanserin), the first-ever approved drug for low libido, or hypoactive sexual desire disorder (HSDD), which affects up to six million pre-menopausal ...

We have recently learned that at this time, the Food and Drug Administration (FDA) has NOT revised its warnings about the use of alcohol with Addyi nor has it changed the drug’s REMS, according to an ...

Three years ago, the holy grail for women with a low sex drive seemed to have arrived. A little pink pill called Addyi—pronounced add-ee and erroneously nicknamed the female Viagra—was the first ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...